Cost of services provided by the National Breast and Cervical Cancer Early Detection Program

Cancer

Volumn 120, Issue SUPPL. 16, 2014, Pages 2604-2611

  Ekwueme, Donatus U ^a   Subramanian, Sujha ^b   Trogdon, Justin G ^c   Miller, Jacqueline W ^a   Royalty, Janet E ^a   Li, Chunyu ^a   Guy, Gery P ^a   Crouse, Wesley ^b   Thompson, Hope ^d   Gardner, James G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

breast cancer screening; cervical cancer screening; cost analysis; economic cost; NBCCEDP; program evaluation

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SCREENING; COST BENEFIT ANALYSIS; COST OF ILLNESS; FEMALE; FUNDING; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UTERINE CERVIX CANCER; WOMEN'S HEALTH; BREAST NEOPLASMS; COST; EARLY DIAGNOSIS; ECONOMICS; INFORMATION PROCESSING; PROCEDURES; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

BREAST NEOPLASMS; COSTS AND COST ANALYSIS; DATA COLLECTION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84905455214     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28816     Document Type: Article

References (38)

1. U.S. Preventive Services Task Force. Prevention and care management. Available at http://www.ahrq.gov/clinic/prevenix.htm.
2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L,. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727-37.
3. U.S. Preventive Services Task Force. Prevention and care management. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed on September 25, 2013.
4. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. Natl Cancer Inst 2011; 103: 714-736.
5. Healthy People 2010 Final Review. Available from URL: www.cdc.gov/nchs/healthy-people/hp2010/hp2010-final-review.htm. Accessed on September 25, 2013.
6. Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM,. Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 2008; 46(7): 692-700.
7. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008; 58: 9-31.
8. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY,. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 2008; 9: 222-231.
9. Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC,. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008; 112: 626-635.
10. Lee NC, Wong FL, Jamison PM, et al. Implementation of the National Breast and Cervical Cancer Early Detection Program: The beginning. Cancer. 2014; 120 (16 Suppl.): 2540-2548.
11. Subramanian S, Ekwueme DU, Gardner JG, Trogdon J,. Developing and testing a cost-assessment tool for cancer screening programs. Am J Prev Med. 2009; 37: 242-247.
12. Schousboe JT, Kerlikowske K, Loh A, Cummings SR,. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011; 155: 10-20.
13. Mandelblatt JS, Schechter CB, Yabroff KR, et al. Toward optimal screening strategies for older women: costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005; 20: 487-496.
14. Poplack SP, Carney PA, Weiss JE, Titus-Ernstoff L, Goodrich ME, Tosteson AN,. Screening mammography: costs and use of screening-related services. Radiology. 2005; 234: 79-85.
15. O'Malley AS, Lawrence W, Liang W, et al. Feasibility of mobile cancer screening and prevention. J Health Care Poor Underserved. 2002; 13: 298-319.
16. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evid Rep Technol Assess (Summ). 1999; 5: 1-6.
17. Kulasingam SL, Myers ER,. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003; 290: 781-789.
18. Schabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA,. Five-year routine cervical cancer screening rates and intervals in a US health plan. Curr Med Res Opin. 2008; 24: 2429-2435.
19. Melnikow J, Kulasingam S, Slee C, et al. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol. 2010; 116: 1158-1170.
20. Goldie SJ, Kim JJ, Wright TC,. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004; 103: 619-631.
21. Gold MR, Siegel JE, Russell L.B, Weinstein MC., Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
22. Yabroff RK, Warren JL, Brown ML,. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol. 2007; 4: 643-656.
23. Greenberg D, Earle C, Fang CH, Eldar-Lissai A, Neumann PJ,. When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology. J Natl Cancer Inst. 2010; 102: 82-88.
24. Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK,. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002; 11: 59-71.
25. Marcus AC, Crane LA,. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med. 1998; 27: 13-31.
26. Meissner HI, Breen N, Coyne C, Legler JM, Green D, Edwards BK,. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998; 7: 951-961.
27. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002; 136: 641-651.
28. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R,. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 1704-1713.
29. Mandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med. 1998; 28: 418-425.
30. Baron RC, Melillo S, Rimer BK, Coates RJ, Kerner J, Habarta N,. Task Force on Community Preventive Services. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: a systematic review of provider reminders. Am J Prev Med, 2010; 38: 110-117.
31. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357-1362.
32. Psooy BJ, Schreuer D, Borgaonkar J, Caines JS,. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004; 55: 145-150.
33. Battaglia TA, Roloff K, Posner MA, Freund KM,. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007; 109 (2 Suppl): 359-367.
34. Ramsey SD, Whitley E, Mears VW, et al. Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer. 2009; 115: 5394-403.
35. Peipins LA, Graham S, Young R, et al. Time and distance barriers to mammography facilities in the Atlanta metropolitan area. J Community Health. 2011; 36: 675-83.
36. Gwyn K, Bondy ML, Cohen DS, et al. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004; 100: 1595-1604.
37. Ekwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD,. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2008; 113: 592-601.
38. Hoerger TJ, Ekwueme DU, Miller JW, et al. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med. 2011; 40: 397-3404.